• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.26% Nasdaq Down 0.34%

    Tekmira Pharmaceuticals Corporation (TKMR)

    -NasdaqCM
    11.57 Down 0.06(0.52%) Jul 6, 4:00PM EDT
    Add to Portfolio
    Prev Close:11.63
    Open:11.25
    Bid:7.00 x 100
    Ask:12.00 x 100
    1y Target Est:24.21
    Beta:-1.65
    Earnings Date:Aug 11 - Aug 17 (Est.)
    Day's Range:11.25 - 11.92
    52wk Range:8.86 - 29.93
    Volume:413,639
    Avg Vol (3m):694,741
    Market Cap:627.37M
    P/E (ttm):N/A
    EPS (ttm):-1.36
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    TKMRDown 0.52%627.37M
    MRNADown 4.26%N/A
    RXIIUp 5.24%31.01M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):41.47
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.18
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Tekmira Pharmaceuticals Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics; and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback